Publications by authors named "Randy Heysek"

Claim this Profile
F
Freedom from Recurrence across Age in Non-Melanoma Skin Cancer Treated with Image-Guided Superficial Radiation Therapy.
Aaron S Farberg, Randy V Heysek, Robert Haber, Rania Agha, Kevin M Crawford

Geriatrics (Basel)· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Image-Guided Superficial Radiation Therapy for Basal and Squamous Cell Carcinomas Produces Excellent Freedom from Recurrence Independent of Risk Factors.
Rania Agha, Randy V Heysek, David B Vasily, Russell Rowe, Erin M McClure

J Clin Med· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perceptions of Prostate Cancer Screening Controversy and Informed Decision Making: Implications for Development of a Targeted Decision Aid for Unaffected Male First-Degree Relatives.
Clement K Gwede, Stacy N Davis, Shaenelle Wilson, Mitul Patel, Susan T Vadaparampil, Randy Heysek

Am J Health Promot· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality-of-life changes due to high-dose-rate brachytherapy, low-dose-rate brachytherapy, or intensity-modulated radiation therapy for prostate cancer.
Tobin J Strom, Alex A Cruz, Nick B Figura, Kushagra Shrinath, Kevin Nethers, Randy V Heysek

Brachytherapy· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in physical functioning and muscle strength in men receiving androgen deprivation therapy for prostate cancer: a controlled comparison.
Brian D Gonzalez, Heather S L Jim, Brent J Small, Steven K Sutton, Mayer N Fishman, Randy V Heysek

Support Care Cancer· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical implications of a prostate-specific antigen bounce after radiation therapy for prostate cancer.
Arash O Naghavi, Tobin J Strom, Kevin Nethers, Alex A Cruz, Nicholas B Figura, Randy V Heysek

Int J Clin Oncol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Depressive symptomatology in men receiving androgen deprivation therapy for prostate cancer: a controlled comparison.
Morgan Lee, Heather S Jim, Mayer Fishman, Babu Zachariah, Randy Heysek

Psychooncology· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
External beam radiation therapy and a low-dose-rate brachytherapy boost without or with androgen deprivation therapy for prostate cancer.
Tobin J Strom, Sean Z Hutchinson, Kushagra Shrinath, Alex A Cruz, Nicholas B Figura, Randy V Heysek

Int Braz J Urol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Informed decision making among first-degree relatives of prostate cancer survivors: a pilot randomized trial.
Stacy N Davis, Steven K Sutton, Susan T Vadaparampil, Cathy D Meade, Brian M Rivers, Randy V Heysek

Contemp Clin Trials· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serial assessment of lymphocytes and apoptosis in the prostate during coordinated intraprostatic dendritic cell injection and radiotherapy.
Steven Eric Finkelstein, Francisco Rodriguez, Mary Dunn, Mary-Jane Farmello, Renee Smilee, Randy Heysek

Immunotherapy· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of external beam radiotherapy (EBRT) with intratumoral injection of dendritic cells as neo-adjuvant treatment of high-risk soft tissue sarcoma patients.
Steven E Finkelstein, Cristina Iclozan, Marilyn M Bui, Matthew J Cotter, Rupal Ramakrishnan, Randy V Heysek

Int J Radiat Oncol Biol Phys· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between polymorphisms in HSD3B1 and UGT2B17 and prostate cancer risk.
Jong Y Park, Jean-Paul Tanner, Thomas A Sellers, Yifan Huang, Colleen K Stevens, Randy Heysek

Urology· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modern brachytherapy for treatment of prostate cancer.
Randy V Heysek

Cancer Control· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A dosimetric analysis of unstranded seeds versus customized stranded seeds in transperineal interstitial permanent prostate seed brachytherapy.
Randy V Heysek, Clement K Gwede, Javier Torres-Roca, Alan Cantor, Stacey Kelley

Brachytherapy· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of intermediate-risk prostate cancer with brachytherapy without supplemental pelvic radiotherapy: a review of the H. Lee Moffitt Cancer Center experience.
Javier F Torres-Roca, Alan B Cantor, Sonia Shukla, Michael E Montejo, Jay Friedland, Randy Heysek

Urol Oncol· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deletion polymorphism of UDP-glucuronosyltransferase 2B17 and risk of prostate cancer in African American and Caucasian men.
Jong Park, Lan Chen, Luke Ratnashinge, Thomas A Sellers, Jean-Paul Tanner, Randy V Heysek

Cancer Epidemiol Biomarkers Prev· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment decision-making strategies and influences in patients with localized prostate carcinoma.
Clement K Gwede, Julio Pow-Sang, John Seigne, Randy Heysek, Mohamed Helal

Cancer· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis